Ray Dogum on Muck Rack

Ray Dogum

Boston
As seen in: Drug Discovery Online, Health Unchained Podcast, LinkedIn, Substack, Nasdaq, Life Science Leader, Bioprocess Online, Pharmaceutical Online, Distributed, Outsourced Pharma, Cell & Gene, Blockchain in Healthcare Today
Podcaster, HealthTech advocate #community #web3 #healthcare #innovation #DeSci #biotech #ai Find me on Drugdiscoveryonline.com 🎙️⛓⚕️📡💊
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ray

Contact Ray, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

iBio Aims To Complement GLP-1s By Preserving Muscle During Weight Loss With Myostatin Antibody

|
By Ray Dogum
| Drug Discovery Online
By Ray Dogum, Chief Editor, Drug Discovery Online As GLP-1 receptor agonists reshape obesity care, a new question is moving to the center of drug development: how can patients lose fat without sacrificing muscle and long-term metabolic health? iBio, Inc. is positioning its lead clinical candidate, iBio600, around that gap. The company is not trying to outcompete GLP-1s on appetite suppression.
Open in Who Shared Issue with article?

06.16.26 -- Fostering Entrepreneurial Mentorship And Education: A Peek Into Nucleate Boston Activator 2026 Cohort

|
By Ray Dogum, Zaher Nahle, Sean Murphy
| Drug Discovery Online
Join leading experts for an insightful discussion on the evolution of targeted protein degradation (TPD) and its growing impact on drug discovery. Explore advances in PROTACs, molecular glues, discovery technologies, modality selection, translational challenges, and safety considerations. Learn how TPD is unlocking new therapeutic opportunities for previously undruggable targets and shaping the future of drug development. Register for free on Drug Discovery Online.
Open in Who Shared Issue with article?

How Rh Incompatibility Endangers Pregnancies And How Rhogam Helped My Family (Part 1 Of 3)

|
By Ray Dogum
| Drug Discovery Online
By Ray Dogum, Chief Editor, Drug Discovery Online The typical drug discovery workflow of finding a biological target, validating it, screening for hits that interact with the target, and selecting and optimizing lead candidates seems logical, but some of the greatest therapeutics ever created came from nonlinear, improvisational, clinically driven science rather than a neat target-to-product sequence.
Open in Who Shared Issue with article?
See all 83 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified